CCB
GMAB icon

Cutter & Co Brokerage’s Genmab GMAB Stock Holding History

Cutter & Co Brokerage’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-117,306
Closed -$3.77M – 222
2022
Q3 		$3.77M Sell
117,306
-2,650
-2% -$93K 1.4% 14
2022
Q2 		$3.9M Buy
119,956
+275
+0.2% +$8.91K 1.33% 13
2022
Q1 		$4.33M Buy
119,681
+186
+0.2% +$6.38K 1.29% 16
2021
Q4 		$4.73M Sell
119,495
-2,140
-2% -$89.2K 1.3% 15
2021
Q3 		$5.32M Sell
121,635
-17,975
-13% -$807K 1.27% 13
2021
Q2 		$5.7M Sell
139,610
-2,850
-2% -$110K 1.31% 11
2021
Q1 		$4.68M Buy
142,460
+20,310
+17% +$764K 1.14% 15
2020
Q4 		$4.97M Sell
122,150
-3,500
-3% -$131K 1.3% 12
2020
Q3 		$4.6M Sell
125,650
-6,675
-5% -$241K 1.36% 13
2020
Q2 		$4.48M Sell
132,325
-13,250
-9% -$361K 1.46% 14
2020
Q1 		$3.08M Sell
145,575
-4,725
-3% -$105K 1.16% 21
2019
Q4 		$3.36M Sell
150,300
-4,700
-3% -$103K 1.18% 21
2019
Q3 		$3.14M Buy
+155,000
New +$3.05M 1.01% 21

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cutter & Co Brokerage's GMAB Position: Q4 2022 in Review

Cutter & Co Brokerage sold out of Genmab (GMAB) in Q4 2022, closing a stake of 117,306 shares — an estimated $3.77M sold.

Cutter & Co Brokerage first reported a position in GMAB in Q3 2019 and held it in 13 quarters. The position peaked at $5.7M in Q2 2021. 237 funds tracked by Wall St. Rank hold GMAB as of Q4 2022.

  • Cutter & Co Brokerage reported no remaining Genmab position as of Q4 2022 after selling out during the quarter.
  • Cutter & Co Brokerage sold 117,306 Genmab shares in Q4 2022, an estimated $3.77M.
  • Cutter & Co Brokerage first reported a position in Genmab in Q3 2019 and held it in 13 quarters.
  • Cutter & Co Brokerage's Genmab position peaked at $5.7M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Genmab as of Q4 2022.

Based on Cutter & Co Brokerage's 13F filing for Q4 2022, filed 3 Feb 2023.